JOURNAL ARTICLE

Melanoma Cancer Immunotherapy Using PD-L1 siRNA and Imatinib Promotes Cancer-Immunity Cycle

Chenyang LiXiuping Han

Year: 2020 Journal:   Pharmaceutical Research Vol: 37 (6)Pages: 109-109   Publisher: Springer Science+Business Media
Keywords:
Cancer research Cytotoxic T cell PI3K/AKT/mTOR pathway Cell cycle Cancer Apoptosis Biology Carcinogenesis Cancer cell Immune checkpoint Immune system Immunotherapy Immunology In vitro

Metrics

41
Cited By
2.41
FWCI (Field Weighted Citation Impact)
30
Refs
0.89
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

Cancer Immunotherapy and Biomarkers
Health Sciences →  Medicine →  Oncology
Immunotherapy and Immune Responses
Life Sciences →  Immunology and Microbiology →  Immunology
CAR-T cell therapy research
Health Sciences →  Medicine →  Oncology
© 2026 ScienceGate Book Chapters — All rights reserved.